VolitionRX (VNRX) Stock Statistics & Valuation Metrics

VolitionRX has a market cap or net worth of $49.08M. The enterprise value is $59.01M.

VolitionRX has 100,775,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

VolitionRX’s return on equity (ROE) is 4.53 and return on invested capital (ROIC) is 1479.95%.

The current PE Ratio of VolitionRX is -1.45. VolitionRX’s PEG ratio is 0.16.

In the last 12 months, VolitionRX had revenue of 775.30K and earned -35.32M in profits. Earnings per share was -0.50.

In the last 12 months, operating cash flow was -13.85M and capital expenditures -683.12K, giving a free cash flow of -14.53M billion.

VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―

VolitionRX upcoming earnings date is May 7, 2025, TBA Not Confirmed.

VolitionRX as a current ratio of 0.69, with Debt / Equity ratio of -27.37%

In the past 12 months, VolitionRX has paid 0.00 in taxes.

VolitionRX EV to EBITDA ratio is -1.06, with an EV/FCF ratio of -1.89.

VolitionRX has $5.41M in cash and marketable securities with $0.00 in debt, giving a net cash position of $472.10K billion.

Gross margin is 21.55%, with operating margin of -4641.76%, and net profit margin of -4555.53%.

The average price target for VolitionRX is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy